Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (002675.SZ)
CNY 12.54
(-0.32%)
CNY 12.54
(-0.32%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 3.27 Billion | 3.58 Billion | 3.91 Billion | 3.41 Billion | 2.99 Billion | 2.33 Billion |
| Cost of Revenue | 1.92 Billion | 2.04 Billion | 2.3 Billion | 1.71 Billion | 1.21 Billion | 995.82 Million |
| Gross Profit | 1.35 Billion | 1.53 Billion | 1.6 Billion | 1.7 Billion | 1.77 Billion | 1.33 Billion |
| Operating Expenses | 1.12 Billion | 959.65 Million | 956.16 Million | 1.03 Billion | 1.1 Billion | 796.12 Million |
| Selling, General and Administrative Expenses | 575.69 Million | 627.32 Million | 667.75 Million | 799.04 Million | 881.82 Million | 616.54 Million |
| Research and Development Expenses | 197.22 Million | 163.52 Million | 137.55 Million | 109.38 Million | 88.71 Million | 64.78 Million |
| Other Expenses | 65.93 Million | 168.8 Million | 150.84 Million | 130.56 Million | 137.63 Million | 114.79 Million |
| Cost and Expenses | 2.93 Billion | 3 Billion | 3.26 Billion | 2.75 Billion | 2.32 Billion | 1.79 Billion |
| Operating Income | 341.66 Million | 448.25 Million | 630.31 Million | 609.14 Million | 603.94 Million | 467.56 Million |
| Interest Expense | 59.31 Million | 58.64 Million | 56.45 Million | 47.79 Million | 46.03 Million | 51.88 Million |
| Income Tax Expense | 83.06 Million | 92.76 Million | 95.24 Million | 93.9 Million | 102.11 Million | 80.95 Million |
| Earnings before Tax | 337.28 Million | 445.57 Million | 356.09 Million | 611.37 Million | 395.75 Million | 469.74 Million |
| Net Income | 209.73 Million | 307.29 Million | 260.84 Million | 417.76 Million | 293.64 Million | 388.79 Million |
| Earnings Per Share Basic | 0.25 | 0.38 | 0.33 | 0.52 | 0.37 | 0.51 |
| Earnings Per Share Diluted | 0.25 | 0.38 | 0.33 | 0.52 | 0.37 | 0.51 |
| Weighted Average Shares Outstanding | 824.75 Million | 807.8 Million | 802.21 Million | 802.21 Million | 802.21 Million | 758.11 Million |
| Weighted Average Shares Outstanding (Diluted) | 824.75 Million | 807.8 Million | 802.21 Million | 802.21 Million | 802.21 Million | 758.11 Million |
| Gross Margin | 0.41 | 0.43 | 0.41 | 0.50 | 0.59 | 0.57 |
| EBIT Margin | 0.16 | 0.20 | 0.19 | 0.23 | 0.23 | 0.27 |
| Profit Margin | 0.06 | 0.09 | 0.07 | 0.12 | 0.10 | 0.17 |
| EBITDA | 528.85 Million | 629.31 Million | 554.56 Million | 767.66 Million | 553.87 Million | 602.1 Million |
| Earnings Before Tax Margin | 0.10 | 0.13 | 0.16 | 0.18 | 0.20 | 0.20 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 741.72 Million | 773.48 Million | 647.22 Million | 690.3 Million | 3.27 Billion | 800.33 Million |
| Cost of Revenue | 391.07 Million | 422.68 Million | 363.78 Million | 353.25 Million | 1.8 Billion | 463.75 Million |
| Gross Profit | 350.64 Million | 350.79 Million | 283.44 Million | 337.04 Million | 1.46 Billion | 336.58 Million |
| Operating Expenses | 238.05 Million | 219.01 Million | 226.39 Million | 239.35 Million | 963.29 Million | 201.1 Million |
| Selling, General and Administrative Expenses | 325.66 Million | 58.21 Million | 178.04 Million | -16.22 Million | - | 241.98 Million |
| Research and Development Expenses | 62.96 Million | 45.71 Million | 45.2 Million | 72.46 Million | - | 40.82 Million |
| Other Expenses | -150.58 Million | -377.62 Thousand | -19.88 Thousand | -23.4 Million | -23.96 Million | -361.51 Thousand |
| Cost and Expenses | 629.12 Million | 641.7 Million | 590.17 Million | 592.6 Million | 2.76 Billion | 664.85 Million |
| Operating Income | 57.99 Million | 73.81 Million | 84 Million | -71.8 Million | 341.66 Million | 135.43 Million |
| Interest Expense | 45.91 Million | 7.08 Million | 14.84 Million | 12.5 Million | 44.32 Million | 10.66 Million |
| Income Tax Expense | 25.26 Million | 19.44 Million | 18.05 Million | 10.85 Million | 83.06 Million | 17.44 Million |
| Earnings before Tax | 56.99 Million | 73.43 Million | 83.98 Million | -75.62 Million | 337.28 Million | 135.07 Million |
| Net Income | 55.07 Million | 47.46 Million | 64.32 Million | -76.07 Million | 209.73 Million | 101.5 Million |
| Earnings Per Share Basic | 0.07 | 0.06 | 0.08 | -0.09 | - | 0.12 |
| Earnings Per Share Diluted | 0.07 | 0.06 | 0.08 | -0.09 | - | 0.12 |
| Weighted Average Shares Outstanding | 824.59 Million | 824.59 Million | 824.71 Million | 825.18 Million | 824.75 Million | 824.59 Million |
| Weighted Average Shares Outstanding (Diluted) | 824.59 Million | 824.59 Million | 824.71 Million | 825.18 Million | 824.75 Million | 824.59 Million |
| Gross Margin | 0.47 | 0.45 | 0.44 | 0.49 | 0.45 | 0.42 |
| EBIT Margin | 0.14 | 0.15 | 0.11 | 0.07 | - | 0.18 |
| Profit Margin | 0.07 | 0.06 | 0.10 | -0.11 | 0.06 | 0.13 |
| EBITDA | 102.91 Million | 116.9 Million | 71.16 Million | 47.32 Million | - | 143.34 Million |
| Earnings Before Tax Margin | 0.08 | 0.10 | 0.13 | -0.10 | 0.10 | 0.17 |
002287
8447
WISA
000705
0519
267250